Reported Standalone quarterly numbers for SMS Pharmaceuticals are:Net Sales at Rs 148.80 crore in December 2022 up 22.72% from Rs. 121.25 crore in December 2021.
Quarterly Net Profit at Rs. 5.03 crore in December 2022 down 52.15% from Rs. 10.51 crore in December 2021.
EBITDA stands at Rs. 20.47 crore in December 2022 down 30.4% from Rs. 29.41 crore in December 2021.
SMS Pharma EPS has decreased to Rs. 0.59 in December 2022 from Rs. 1.24 in December 2021.
| SMS Pharma shares closed at 67.75 on March 13, 2023 (NSE) and has given -28.83% returns over the last 6 months and -30.01% over the last 12 months. |
| SMS Pharmaceuticals |
| Standalone Quarterly Results |
in Rs. Cr. |
|
|
Dec’22 |
Sep’22 |
Dec’21 |
| Net Sales/Income from operations |
148.80 |
159.43 |
121.25 |
| Other Operating Income |
— |
— |
— |
| Total Income From Operations |
148.80 |
159.43 |
121.25 |
| EXPENDITURE |
| Consumption of Raw Materials |
75.74 |
87.69 |
100.44 |
| Purchase of Traded Goods |
— |
— |
— |
| Increase/Decrease in Stocks |
21.89 |
28.20 |
-39.27 |
| Power & Fuel |
— |
— |
— |
| Employees Cost |
13.57 |
13.06 |
13.21 |
| Depreciation |
8.12 |
8.09 |
8.10 |
| Excise Duty |
— |
— |
— |
| Admin. And Selling Expenses |
— |
— |
— |
| R & D Expenses |
— |
— |
— |
| Provisions And Contingencies |
— |
— |
— |
| Exp. Capitalised |
— |
— |
— |
| Other Expenses |
19.34 |
16.86 |
19.59 |
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
10.14 |
5.53 |
19.18 |
| Other Income |
2.21 |
0.61 |
2.13 |
| P/L Before Int., Excpt. Items & Tax |
12.35 |
6.14 |
21.31 |
| Interest |
5.94 |
5.24 |
4.75 |
| P/L Before Exceptional Items & Tax |
6.42 |
0.90 |
16.56 |
| Exceptional Items |
— |
— |
— |
| P/L Before Tax |
6.42 |
0.90 |
16.56 |
| Tax |
1.39 |
0.11 |
6.06 |
| P/L After Tax from Ordinary Activities |
5.03 |
0.79 |
10.51 |
| Prior Year Adjustments |
— |
— |
— |
| Extra Ordinary Items |
— |
— |
— |
| Net Profit/(Loss) For the Period |
5.03 |
0.79 |
10.51 |
| Equity Share Capital |
8.47 |
8.47 |
8.47 |
| Reserves Excluding Revaluation Reserves |
— |
— |
— |
| Equity Dividend Rate (%) |
— |
— |
— |
| EPS Before Extra Ordinary |
| Basic EPS |
0.59 |
0.09 |
1.24 |
| Diluted EPS |
0.59 |
0.09 |
1.24 |
| EPS After Extra Ordinary |
| Basic EPS |
0.59 |
0.09 |
1.24 |
| Diluted EPS |
0.59 |
0.09 |
1.24 |
| Public Share Holding |
| No Of Shares (Crores) |
— |
— |
— |
| Share Holding (%) |
— |
— |
— |
| Promoters and Promoter Group Shareholding |
| a) Pledged/Encumbered |
| – Number of shares (Crores) |
— |
— |
— |
| – Per. of shares (as a % of the total sh. of prom. and promoter group) |
— |
— |
— |
| – Per. of shares (as a % of the total Share Cap. of the company) |
— |
— |
— |
| b) Non-encumbered |
| – Number of shares (Crores) |
— |
— |
— |
| – Per. of shares (as a % of the total sh. of prom. and promoter group) |
— |
— |
— |
| – Per. of shares (as a % of the total Share Cap. of the company) |
— |
— |
— |
| Source : Dion Global Solutions Limited |
|
